Health Systems Research Unit, Medical Research Council, Francie van Zyl Drive, Tygerberg, South Africa.
BMC Public Health. 2009 Nov 5;9:406. doi: 10.1186/1471-2458-9-406.
Despite several years of implementation, prevention of mother-to-child transmission (PMTCT) programmes in many resource poor settings are failing to reach the majority of HIV positive women. We report on a data driven participatory quality improvement intervention implemented in a high HIV prevalence district in South Africa.
A participatory quality improvement intervention was implemented consisting of an initial assessment undertaken by a team of district supervisors, workshops to assess results, identify weaknesses and set improvement targets and continuous monitoring to support changes.
The assessment highlighted weaknesses in training and supervision. Routine data revealed poor coverage of all programme indicators except HIV testing. Monthly support to all facilities took place including an orientation to the PMTCT protocol, review of local data and identification of bottlenecks to optimal coverage using a continuous quality improvement approach. One year following the intervention large improvements in programme indicators were observed. Coverage of CD4 testing increased from 40 to 97%, uptake of maternal nevirapine from 57 to 96%, uptake of infant nevirapine from 15 to 68% and six week PCR testing from 24 to 68%.
It is estimated that these improvements in coverage could avert 580 new infant infections per year in this district. This relatively simple participatory assessment and intervention process has enabled programme managers to use a data driven approach to improve the coverage of this important programme.
尽管已经实施了多年,许多资源匮乏的环境中的母婴传播预防(PMTCT)计划仍未能覆盖大多数 HIV 阳性妇女。我们报告了在南非一个高 HIV 流行地区实施的数据驱动的参与式质量改进干预措施。
实施了一项参与式质量改进干预措施,该措施由一组地区主管进行的初步评估、评估结果、确定弱点和设定改进目标以及持续监测以支持变革的研讨会组成。
评估突出了培训和监督方面的弱点。常规数据显示,除 HIV 检测外,所有方案指标的覆盖率都很差。每月向所有设施提供支持,包括对 PMTCT 方案的介绍、对当地数据的审查以及使用持续质量改进方法确定最佳覆盖范围的瓶颈。干预一年后,方案指标有了显著改善。CD4 检测覆盖率从 40%提高到 97%,产妇奈韦拉平的使用率从 57%提高到 96%,婴儿奈韦拉平的使用率从 15%提高到 68%,六周 PCR 检测的使用率从 24%提高到 68%。
据估计,这些覆盖率的提高可以避免该地区每年新增 580 例婴儿感染。这种相对简单的参与式评估和干预过程使项目管理人员能够使用数据驱动的方法来提高这一重要项目的覆盖率。